Glomeria Therapeutics Overview

  • Founded
  • 2010

  • Status
  • Out of Business

  • Employees
  • 4

  • Latest Deal Type
  • Out of Business

Glomeria Therapeutics General Information


Developer of drugs and medical devices intended to treat and cure serious nephrological diseases. The company engages in the research and development of products for the treatment of severe forms of nephropathy and cardiopathy and which help in developing a structure that minimizes infrastructure costs and maximizes access to scientific knowledge and biomedical research, enabling doctors to treat patients with diseases like peritoneal dialysis, chronic renal failure, hemodialysis and hemofiltration.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Diagnostic Equipment
Primary Office
  • Via Padre Ugolino Frasca, 204
  • Scala B - Int. 11
  • 66100 Chieti(CH)
  • Italy
+39 0871 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glomeria Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 05-Oct-2020 00.000 Completed Out of Business
5. Secondary Transaction - Private 01-Dec-2017 00.000 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2017 00.000 Completed Generating Revenue
3. Grant 06-Jul-2016 00.000 00.000 Completed Clinical Trials - Phase 3
2. Early Stage VC 31-Jul-2015 $1.44M $6.83M Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 15-Apr-2010 $5.4M $5.4M Completed Startup
To view Glomeria Therapeutics’s complete valuation and funding history, request access »

Glomeria Therapeutics Patents

Glomeria Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014272705-A1 Connecting device Inactive 28-May-2013 0000000000
CA-2912992-A1 Connecting device Inactive 28-May-2013 0000000000
EP-3003460-B1 Connecting device Inactive 28-May-2013 0000000000
EP-3003460-A1 Connecting device Active 28-May-2013 0000000000
US-20160129236-A1 Connecting device Inactive 28-May-2013 A61M39/165 0
To view Glomeria Therapeutics’s complete patent history, request access »

Glomeria Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial